Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
永泰生物CEO辭任 指控有董事失責卻干預營運
2025-06-02T  
永泰生物核心候選產品EAL附條件新藥上市申請獲藥監局受理
2025-03-31T  
華潤醫藥參股公司細胞免疫治療產品獲准向內地提交附條件批准申請
2025-03-03T  
永泰生物-B治療白血病注射液獲授突破性療法認定
2024-12-11T  
永泰生物以10萬人幣獲永泰瑞科全部股權 解除合約安排
2024-12-03T  
弘業期貨A股股票交易異常波動
2024-09-19T  
《業績》永泰生物中期虧損收窄至9,252萬人民幣
2024-08-25T  
永泰生物-B首席財務官辭任
2024-07-28T  
永泰生物出售大額存單 呈利息收入260萬人民幣
2024-06-21T  
《公司業績》永泰生物-B全年虧損擴大至3.35億元人民幣
2024-04-01T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.